These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27806304)

  • 81. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer.
    Tran N; Broun A; Ge K
    Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32817139
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease.
    Xu L; Fan YH; Zhang XJ; Bai L
    World J Hepatol; 2024 May; 16(5):703-715. PubMed ID: 38818286
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Histone methylation: at the crossroad between circadian rhythms in transcription and metabolism.
    González-Suárez M; Aguilar-Arnal L
    Front Genet; 2024; 15():1343030. PubMed ID: 38818037
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Histone Modifications in NAFLD: Mechanisms and Potential Therapy.
    Shi Y; Qi W
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834101
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.
    Zaiou M
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190114
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Molecular insights of KMT2D and clinical aspects of Kabuki syndrome type 1.
    Golden CS; Williams S; Serrano MA
    Birth Defects Res; 2023 Nov; 115(19):1809-1824. PubMed ID: 37158694
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Identification and Evaluation of Hub Long Noncoding RNAs and mRNAs in High Fat Diet Induced Liver Steatosis.
    Sui J; Pan D; Yu J; Wang Y; Sun G; Xia H
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839306
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview.
    Charidemou E; Koufaris C; Louca M; Kirmizis A; Rubio-Tomás T
    Clin Transl Oncol; 2023 Jun; 25(6):1594-1605. PubMed ID: 36650321
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies.
    Gutiérrez-Cuevas J; Lucano-Landeros S; López-Cifuentes D; Santos A; Armendariz-Borunda J
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612019
    [TBL] [Abstract][Full Text] [Related]  

  • 90. LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2.
    Wang H; Wang Y; Lai S; Zhao L; Liu W; Liu S; Chen H; Wang J; Du G; Tang B
    Cell Death Discov; 2022 Nov; 8(1):449. PubMed ID: 36344496
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer.
    Zhai Q; Luo M; Zhang Y; Zhang W; Wu C; Lv S; Wei Q
    Transl Cancer Res; 2022 Aug; 11(8):2607-2621. PubMed ID: 36093518
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nutrition, metabolism, and epigenetics: pathways of circadian reprogramming.
    Sato T; Sassone-Corsi P
    EMBO Rep; 2022 May; 23(5):e52412. PubMed ID: 35412705
    [TBL] [Abstract][Full Text] [Related]  

  • 93. An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease.
    Rodríguez-Sanabria JS; Escutia-Gutiérrez R; Rosas-Campos R; Armendáriz-Borunda JS; Sandoval-Rodríguez A
    Front Med (Lausanne); 2021; 8():770504. PubMed ID: 35087844
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease.
    Cai Q; Gan C; Tang C; Wu H; Gao J
    Front Pharmacol; 2021; 12():784591. PubMed ID: 34887768
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Histone Demethylase KDM7A Contributes to the Development of Hepatic Steatosis by Targeting Diacylglycerol Acyltransferase 2.
    Kim JH; Nagappan A; Jung DY; Suh N; Jung MH
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681759
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.
    Zaiou M; Amrani R; Rihn B; Hajri T
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572442
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Epigenetic regulation of energy metabolism in obesity.
    Gao W; Liu JL; Lu X; Yang Q
    J Mol Cell Biol; 2021 Oct; 13(7):480-499. PubMed ID: 34289049
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases.
    Asif S; Morrow NM; Mulvihill EE; Kim KH
    Front Genet; 2020; 11():590369. PubMed ID: 33193730
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
    Kim JH; Jung DY; Kim HR; Jung MH
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Transcriptional regulation by methyltransferases and their role in the heart: highlighting novel emerging functionality.
    Szulik MW; Davis K; Bakhtina A; Azarcon P; Bia R; Horiuchi E; Franklin S
    Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H847-H865. PubMed ID: 32822544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.